We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$29.6B
AUM Growth
+$4.22B
(+17%)
Cap. Flow
+$2.91B
Cap. Flow
% of AUM
9.83%
Top 10 Holdings %
Top 10 Hldgs %
7.91%
Holding
2,390
New
174
Increased
1,221
Reduced
844
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$184M |
| 2 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$158M |
| 3 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$136M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$123M |
| 5 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$120M |
| 2 |
Conagra Brands
CAG
|
+$72.2M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$61.5M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
+$55.9M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$50.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 12.87% |
| 3 | Consumer Discretionary | 10.2% |
| 4 | Consumer Staples | 9.25% |
| 5 | Industrials | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| $314M | 1.06% |
3,073,799
+1,619,304
| +111% | +$158M |
|
2
Meta Platforms (Facebook)
META
$1.54T
| $277M | 0.93% |
3,547,690
+13,787
| +0.4% | +$1.05M |
|
|
3
First Trust Health Care AlphaDEX Fund
FXH
$1.01B
| $266M | 0.9% |
4,411,143
+2,323,696
| +111% | +$136M |
|
|
4
First Trust Consumer Staples AlphaDEX Fund
FXG
$229M
| $241M | 0.81% |
5,670,902
+2,987,319
| +111% | +$123M |
|
5
Alphabet (Google) Class C
GOOG
$3.89T
| $241M | 0.81% |
9,151,537
+1,405,789
| +18% | +$37.7M |
|
|
6
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.84B
| $237M | 0.8% |
3,871,606
+2,039,605
| +111% | +$123M |
|
7
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$259M
| $234M | 0.79% |
6,535,711
+3,442,898
| +111% | +$116M |
|
|
8
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
| $181M | 0.61% |
3,643,253
+3,635,853
| +49,133% | +$184M |
|
9
AT&T
T
$157B
| $180M | 0.61% |
7,076,429
+1,835,476
| +35% | +$47.6M |
|
10
Intel
INTC
$504B
| $173M | 0.58% |
4,771,558
+261,630
| +6% | +$9.1M |
|
11
Amazon
AMZN
$2.51T
| $169M | 0.57% |
10,884,180
+656,460
| +6% | +$10.2M |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $158M | 0.53% |
1,409,558
-4,567
| -0.3% | -$482K |
|
13
Amgen
AMGN
$201B
| $141M | 0.48% |
887,351
+94,300
| +12% | +$14.7M |
|
14
Regeneron Pharmaceuticals
REGN
$68.3B
| $136M | 0.46% |
330,546
+88,944
| +37% | +$35M |
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
| $135M | 0.45% |
728,827
+25,874
| +4% | +$4.79M |
|
16
Gilead Sciences
GILD
$162B
| $133M | 0.45% |
1,406,181
-139,014
| -9% | -$14.4M |
|
17
Biogen
BIIB
$29.6B
| $130M | 0.44% |
383,756
+19,583
| +5% | +$6.34M |
|
18
eBay
EBAY
$48.5B
| $130M | 0.44% |
5,500,832
+422,952
| +8% | +$9.6M |
|
19
Cisco
CSCO
$444B
| $126M | 0.43% |
4,546,391
+111,104
| +3% | +$2.87M |
|
20
Chevron
CVX
$387B
| $126M | 0.43% |
1,126,381
+272,162
| +32% | +$30.9M |
|
21
United Therapeutics
UTHR
$26.4B
| $124M | 0.42% |
955,531
+210,055
| +28% | +$27.1M |
|
22
Altria Group
MO
$120B
| $123M | 0.41% |
2,490,792
+898,978
| +56% | +$43.8M |
|
23
Verizon
VZ
$183B
| $122M | 0.41% |
2,615,372
+578,055
| +28% | +$28.3M |
|
24
Apple
AAPL
$4.72T
| $122M | 0.41% |
4,426,076
-12,168
| -0.3% | -$331K |
|
|
YHOO
25
DELISTED
Yahoo Inc
YHOO
| $121M | 0.41% |
2,390,497
-26,588
| -1% | -$1.25M |
|
Similar funds
DAM
First Trust Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, First Trust Advisors held 2,390 positions worth $29.6B, up 17% from $25.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
First Trust Advisors deployed $2.91B of net new capital in Q4 2014, opening 174 new positions and adding to 1,221 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $120M trimmed.
- First Trust Advisors's largest Q4 2014 buy was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
- First Trust Advisors added most to First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF in Q4 2014, an estimated $184M increase.
- First Trust Advisors's biggest Q4 2014 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $120M.
- First Trust Advisors fully exited Immunogen Inc in Q4 2014, selling an estimated $61.5M.
- First Trust Advisors's ten largest holdings make up 7.9% of its $29.6B portfolio in Q4 2014.
- First Trust Advisors opened 174 new positions and closed 147 in Q4 2014.
- First Trust Advisors's portfolio value rose 17% quarter-over-quarter to $29.6B.
Based on First Trust Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.